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Abstract
Background: Legal, ethical, and psychological arguments indicate that patients need to receive information about their
health situations before their care decisions are made. Patient decision aids (PtDAs) are designed to help patients make
decisions; therefore, they should provide information that results in patients understanding their health situation. We
reviewed studies that assessed the impact of PtDAs on patient knowledge and on their feeling of being uninformed.
Methods: Our data sources were a published Cochrane Collaboration review that included randomized controlled
trials (RCTs) published before 2010 and a systematic review we conducted of RCTs published in 2010. We included
trials that compared 1) PtDAs to usual care, and 2) PtDAs with simple information to PtDAs with more detailed
information. Outcomes included patients’ knowledge and their feeling of being uninformed. Data were analyzed
quantitatively and qualitatively. Meta-analyses of similar studies estimated the size of differences.
Results: Thirty-nine RCTs compared a PtDA to usual care and all showed higher knowledge scores for patients in
the PtDA groups; a meta-analysis estimated the advantage at 14 (of 100) points. Sixteen (of 39) studies used the
Feeling Uninformed subscale; a meta-analysis estimated a reduction of 7 (of 100) points in the PtDA group over
usual care. Twenty-one studies compared simple- to more-detailed information in PtDAs. There was a small overall
advantage for more detailed information on knowledge scores; a meta-analysis estimated the advantage at 5 (of
100) points. Only one study found higher mean knowledge scores for simpler information. Nine (of 21) studies
reported using the Feeling Uninformed subscale and a meta-analysis suggested a reduction of 3 (of 100) points for
the more-detailed PtDAs over those with simpler information. Only one study found that simpler information
resulted in patients feeling more informed.
Conclusions: It appears that PtDAs result in patients having higher knowledge scores and in reduced feelings of
being uninformed over patients who receive usual care. It also appears that PtDAs with more detailed information
generally result in slightly higher knowledge and lower “Feeling Uninformed” scores than those with simpler
information, but the differences are small and can be reversed under some circumstances.
Background
For patients to make decisions about their care, they
need to have knowledge about their health situations and
the options being offered to them. For patients to have
this knowledge, they must be provided with relevant
information. Since patient decision aids (PtDAs) are
intended to help patients make decisions about their
care, a core aspect of their design is the provision of that
relevant information.
A definition
The selection of the relevant information that should be
included in PtDAs is guided by informed consent
requirements as well as by patient reports about the
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information that they need. Thus, the relevant informa-
tion in PtDAs should include:
• How the untreated condition is expected to
develop.
• The procedures involved in each treatment option.
• The potential benefits – including their likelihoods
– of each treatment option.
• The side effects and potential harms – including
their severity and their associated likelihoods – of
each treatment option.
• For screening or diagnostic tests …
○ the frequency of true/false positive and true/
false negative results, and
○ the recommended follow-up actions that could
include treatment options for true positive
results
• In addition, patients’ information needs that are
outside these content areas also need to be identified
and addressed.
Purpose
The purpose of this paper is to present the theoretical
justification for evaluating PtDAs according to the qual-
ity dimension of ‘providing information about options’,
to review the current empirical evidence for such eva-
luation, and to identify and discuss some emerging theo-
retical, evidentiary, and research issues about the
provision of information in PtDAs.
Theoretical justification for evaluating patient
decision aids on this quality dimension
The argument that patients need to have knowledge in
order to make a decision—and, hence, the argument that
information should be provided in a PtDA—has several
theoretical foundations. Below, we touch on two such
foundations: the ethical and legal imperatives of informed
consent, and the ways in which decision-making theories
highlight patient information needs.
Ethical and legal obligations of informed consent
Healthcare providers are bound by the ethical doctrine of
informed consent, which is founded on three principles:
(1) autonomy (which obligates the providers to ensure
that the patients can act in their own best interest without
undue pressure); (2) beneficence and non-malfeasance
(which obligates the providers to choose to do good and
to avoid doing harm to patients); and (3) distributive jus-
tice (which obligates the providers to treat all patients
equally) [1,2]. The implication of these ethical principles is
that healthcare providers need to ensure that all patients
have equal access to the information deemed important to
the decision.
In most jurisdictions, there is a legal obligation of
informed consent. This obligation makes healthcare provi-
ders responsible for ensuring that patients understand
their condition, all available tests or treatments–including
doing nothing–and each treatment’s potential benefits and
harms.
In the context of informed consent, specifying which
details to cover has built on legal precedent, making use
of “standards”. Three standards have emerged over time,
each attempting to compensate for deficiencies of the
previous one. The first was the “Professional” Standard,
which refers to the information that doctors agree
should be provided. When the Professional Standard did
not capture what was important to patients [3], it was
replaced with the “Objective” Standard, that which a
“reasonable” person in the patient’s position would need
to be provided (as decided by a jury). Differences
between patients in what they consider important to the
decision has led to the third standard, the “Subjective”
Standard, that which the individual patient deems
important to the decision [1]. Intrinsic to the standards
is that the information should be evidence-based as
much as possible, using the best quality evidence avail-
able [4] (see also in this special supplement: Montori et
al., “Basing information on comprehensive, critically
appraised, and up-to-date syntheses of the scientific
evidence”).
Decision-making theories highlight patient information
needs
Prescriptive theories of decision making (e.g., Expected
Utility Theory [5]) and descriptive theories of decision
making (e.g., Behavioral Decision Framework [6]; Conflict
Model [7]; Differentiation and Consolidation [8]; Fuzzy
Trace Theory [9]; Image Theory [10]; Parallel Constraint
Satisfaction [11]; and Search for Dominance Structure
[12]) all suggest that, to make a decision, the decision
maker needs a) to develop a knowledge base that’s relevant
to the decision problem, and then b) to establish their
knowledge-based preferences for particular aspect(s) of
the options or for an option as a whole. Therefore, a wide
range of psychological theories imply that patients con-
templating a health care decision need to be provided with
information from which to derive a relevant knowledge
base and, thereafter, upon which to formulate their prefer-
ences. However, while some information may be clearly
relevant to all decision makers for a given decision, the
relevance of some other aspects of information may vary
from person to person.
The implication of all these theories is that, for them
to make decisions, patients need information that is
relevant to their individual needs. This implication cre-
ates a particular challenge for PtDA designers because
empirical evidence suggests that patients’ information
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needs for decision making often differ from the informa-
tion priorities of their healthcare providers [13], and
furthermore, that the information needs often vary con-
siderably from one patient to the next [14-16].
Empirical evidence for evaluating patient decision
aids on this quality dimension
The theoretical underpinnings outlined above indicate
that patients facing health care decisions need to be pro-
vided with appropriate information so that they have the
knowledge required to arrive at preference-based choices.
One could argue that, in regular clinical practice alone,
patients already receive such information and already use
it to formulate the knowledge base they need to make
choices. If this is so, then the use of PtDAs to help in the
process of information provision is, in effect, moot, and,
by extension, it’s not worth including the quality dimen-
sion of ‘providing information about options’ in the roster
of evaluative dimensions used to assess the adequacy of a
PtDA. Therefore, we asked the first-order review ques-
tion: “What is the quality of the evidence that PtDAs aug-
ment patients’ knowledge?”
(Note that it is beyond the scope of this paper to present
overviews of additional second-order review questions.
Such second-order reviews could include, for example,
examinations of a) the empirical evidence about whether
or not PtDA developers conduct appropriate preliminary
studies to identify patient information needs that exceed
the requirements of Informed Consent, or b) the empirical
evidence about the extent to which current PtDAs actually
provide the content that meets Informed Consent require-
ments (e.g., [17]. These would, indeed, be important addi-
tional review topics to undertake, if, in fact, the empirical
evidence indicates that PtDAs, in general, foster higher
levels of patient knowledge.)
Sources and strategies
In the sections below, we synthesize the results of two
systematic reviews. One is a Cochrane Collaboration
review of the published reports about the effects of
PtDAs tested in randomized controlled trials (RCTs) up
to the end of 2009 [18] This Cochrane Collaboration’s
review identified 50 such RCTs.
The other review supplemented the first; we identified
2010 publications reporting PtDA RCTs up to the end
of 2010 by searching OvidSP, including all databases
(e.g., Medline, AMED, EBM Reviews, EMBASE, Global
Health, Ovid Healthstar, PsycExtra, PsychInfo), and
using the search terms: (“decision aid” or “decision sup-
port” or “decision making”) AND (“randomized trial” or
“controlled trial” or “comparison”). This 2010 search
identified an additional 10 trials. All 60 of these reports
of RCTs evaluating the effect of PtDAs on knowledge
involved patients facing actual choices.
In examining data, we focused on two types of studies : 1)
interventions in which a patient uses a PtDA compared to
patients who receive usual care, and 2) PtDAs with simple-
as compared to more-detailed information. Within each
type of study, we focused on two outcomes related to the
effects of providing information about options: objective
patient knowledge scores; and subjective self-reports of
how well-informed patients feel.
PtDAs versus usual care
Of the 60 RCTs, 39 compared a PtDA to “usual care”,
which we defined as no intervention beyond that usually
given in the study setting.
Effects on objective knowledge scores
Among these 39, the 2011 Cochrane Collaboration review
[18] included a meta-analysis of 26 studies that compared
PtDAs to usual care in terms of the effects on knowledge
scores. It found that patients using PtDAs had mean
knowledge scores that were, on average, 14 out of 100
points higher (95% CI: 11 to 16) than the mean scores of
patients who received usual care. This Cochrane Colla-
boration review also identified an additional 8 studies that
could not be included in the meta-analysis. Of these, 5
reported statistically significant improvement in knowl-
edge scores in PtDA groups compared to usual care,
although one [19] showed the advantage only if the PtDA
was used during the consultation (and not when it was
used prior to the consultation). The other 3 studies
reported a statistically significant improvement from base-
line for DA groups.
Our supplementary review identified five additional
trials published in 2010 that compared PtDA to usual
care in terms of the effects on knowledge scores. All 5
reported statistically significantly improved knowledge
for the PtDA group. Two reported higher mean knowl-
edge scores [20,21]; 2 reported larger mean improve-
ment from baseline scores [22,23]; and the fifth study
reported that a larger percentage of PtDA patients
improved their knowledge scores and that there was a
statistically significant larger mean improvement in
scores for the PtDA group [24].
Thus, overall, it appears that providing patients with a
PtDA results in higher objectively-assessed knowledge
scores than those who receive usual care.
Effects on subjective “feeling informed” scores
Most frequently, patients’ subjective reports have been
measured by the “Feeling Uninformed” subscale of the
Decisional Conflict Scale (DCS, [25]). The 2011
Cochrane Collaboration review [18] identified 16 studies
that reported observations obtained on the Decisional
Conflict Scale “Feeling Uninformed” subscale, and a
meta-analysis of those data found a 7-point (out of 100
points) reduction in reports of feeling uninformed (95%
CI: -9 to -4). (In our supplementary review of the five
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additional studies identified in 2010 that compared
PtDAs versus usual care, none reported their observa-
tions on the “Feeling Uninformed subscale”, even when
the investigators had used the Decisional Conflict Scale.)
Evidence gathered using objectively-assessed knowl-
edge scores is currently considered the “gold standard”
measure of information comprehension. However, the
subjectively-gathered data reported in the 2011 Cochrane
Collaboration review imply that providing patients with a
PtDA also results in those patients feeling as if they are
better informed than those who received usual care.
Simple versus more detailed PtDAs
Twenty-one of the 60 trials compared a simpler to a
more-detailed PtDA; we defined “more-detailed” as pro-
viding information (with or without other components
added to the PtDAs) that was not provided in the “sim-
ple” PtDA.
Effects on objective knowledge scores
The 2011 Cochrane Collaboration review [18] included a
meta-analysis of 14 trials that compared simple to more-
detailed PtDAs and found that, on average, the more-
detailed decision aids resulted in a 5-point (out of 100
points) improvement in mean knowledge scores beyond
the gains in knowledge scores induced by the simple PtDA
(95% CI: 3 to 7), which is considered a small effect. One
study that could not be included in this analysis found no
difference between the groups [26].
Our supplementary review identified five studies that
compared simple to more-detailed PtDAs. Of these,
three found some statistically significant evidence of
higher knowledge scores for the more-detailed PtDA.
However, among these three, the differences often were
limited. One found a higher mean knowledge score [27],
one found a significant improvement in mean knowl-
edge scores from baseline in the more-detailed PtDA
group but not in the simpler-PtDA group [28], and one
found no difference in mean overall knowledge scores,
although the more-detailed group had more accurate
perceptions of the risks deemed most important to the
decision [29]. The fourth study reported no difference in
mean knowledge scores between the groups [30]. The
final, fifth, study was designed for low-literacy patients,
so the intervention PtDA contained less information
and used simpler language and graphic illustrations
compared to the standard information provided to the
control group. The authors reported that the group who
received less information (in simpler language with gra-
phics) had higher mean knowledge scores, and that a
statistically significantly larger proportion of participants
reached the knowledge threshold that the authors
defined for “informed decision making” [31].
Thus, it generally appears that the more-detailed
PtDAs seem to result in slightly higher knowledge
scores than the simpler PtDAs, but the differences are
very small, often isolated, and it appears that they can
be reversed under some circumstances.
Effects on subjective “feeling informed” scores
The 2011 Cochrane Collaboration review [18] included
a meta-analysis of the results of 9 studies that compared
simple to more-detailed patient PtDAs in terms of
patients’ “Feeling Uninformed” scores. The analysis
revealed that the more-detailed PtDAs resulted in a
slight 3-point (out of 100 points) reduction in feeling
uninformed (95% CI: -5 to 0).
Of the five studies comparing simple to more-detailed
PtDAs that were identified in our supplementary review,
two found that the more-detailed PtDA reduced “Feeling
Uninformed” scores significantly more than the simple
PtDA [28,29]. In the study of patients with low literacy,
the patients who received the PtDA that presented less
information in simpler language and that used graphic
illustrations reported higher scores on the low-literacy ver-
sion of the “Feeling Uninformed” subscale (65% versus
52%) [31]. Two of the five studies did not find a difference
between the groups’ scores on the DCS “Feeling Unin-
formed” subscale [27,30]. However, one of those studies
did find that a significantly higher percentage of the more-
detailed PtDA group reported having enough information
to make a decision (89% versus 80%) [27]. Thus, parallel
to the knowledge-score comparisons, it appears that more
detailed information seems to result in slightly higher
“Feeling Informed” scores but the differences are small,
often isolated, and it appears they can be reversed under
some circumstances.
Taken together, it appears that patients using PtDAs
show improved objective knowledge scores and
improved feelings about being informed over patients
who receive usual care. (It also appears that, typically,
more detailed information offers patients a slight benefit
over those who receive simple information in their
PtDAs, but the advantage is small, not always realized,
and can be reversed.) Therefore, the empirical evidence
indicates that the use of PtDAs to help in the process of
information provision is not a trivial action, and, by
extension, it is important to include the quality dimen-
sion of ‘providing information about options’ in the ros-
ter of evaluative dimensions used to assess the adequacy
of a PtDA.
Discussion
This review began by suggesting that the legal and ethi-
cal obligations for informed consent, along with pre-
scriptive and descriptive theories of decision making, all
argue for providing information about options to
patients so that patients have the knowledge they need
in order to make care decisions. Therefore, whether or
not it’s worthwhile to assess the quality of PtDAs in
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terms of its information-provision depends on whether
or not such PtDAs are actually capable of improving
patients’ knowledge. Empirical evidence suggests that
this is so – because patients feel more informed and are
actually more informed when the information is pre-
sented in a PtDA than as part of usual care. The results
of comparisons of more-detailed and simpler PtDAs are
less clear, but it appears that the more-detailed PtDAs
tend to be slightly more helpful to most patients than
the simpler ones.
As we have indicated above, for patients to have the
information that they require to make a decision, the
content provided in a PtDA typically needs to go
beyond that which fulfills Informed Consent obligations.
Below, we identify some issues that complicate the iden-
tification of such content, we present relevant evidence,
and we discuss the implications of each information-
identification issue. In addition to these complications,
what patients actually understand about their decision is
affected not only by what information is provided but
also by how it is provided. Below, we identify some pre-
sentation issues, provide evidence relevant to those
issues, and highlight where needed evidence is not yet
available.
Content-related issues
As noted above, identifying patients’ information needs
is an important aspect of developing PtDAs (see also in
this special supplement: Coulter A et al, “A Systematic
Development Process for Patient Decision Aids”). Three
issues are emerging as important when identifying those
needs.
The first issue is that investigations need to drill down
to the details that are important, rather than relying on
identifying broad categories that patients are interested
in, and then assuming that it is clear which details are
important. For example, patients with early-stage pros-
tate cancer concerned about “the cancer spreading” can
be concerned about the chances of the cancer spreading,
which is assumed and true for some patients, but some
patients are concerned about where the cancer will
spread (e.g., wanting to avoid brain metastases more
than metastases to other parts of the body) [32]. Thus,
while it is increasingly accepted that patients’ informa-
tion priorities often differ from those of their healthcare
providers [13,33], the extent of the differences is not yet
clear. For each decision, investigation of the detailed
information that affects patients’ decisions will help clar-
ify what information should be provided in a PtDA for
that decision.
The second issue that is emerging is the wide variabil-
ity within patient populations in what information they
want [15,34,35]. Although a review of PtDAs suggests
that developers frequently rely on focus group and/or
interviews with patients to identify their needs [17], it is
only through systematic quantitative study that variabil-
ity can be identified. The qualitative studies help ensure
depth of understanding, but quantitative study for each
decision will help determine (a) which needs are most
prevalent, and (b) the extent of variability in particular
needs across patients.
The third issue is that information that patients need
for decision making can extend beyond that which is
necessary to select one option from among those
offered. Additional needs include bolstering behavioral
intentions (e.g., the Theory of Planned Behavior [36]),
bolstering self-efficacy (e.g., the Theory of Reasoned
Action [37]), decreasing anxiety or enhancing comfort
levels with the decision process or the decision itself,
and adjusting processes to match the individual’s style
of information-seeking in decision making (e.g., infor-
mation “blunting” versus “monitoring” [38]). It is impor-
tant for empirical studies to identify what is required for
the broader range of decision-making needs so that they
can be addressed. After information for the broader
range of needs is presented, the PtDA can explicitly
help the patient identify what is important to him/her
specifically in selecting their preferred option—a strategy
that has been used successfully[39]. Variability in infor-
mation needs within populations presents particular
challenges to PtDA developers. Because PtDAs are
intended to help the individual patient with her/his deci-
sion, it is important to be able to accommodate wide
variability in information needs within a patient popula-
tion. While there is some evidence for strategies that
appear to be effective [40]; [39], further research is
needed to determine the best ways of tailoring patient
PtDAs to address the information needs of the indivi-
dual patient, both within and outside busy clinical
practices.
Presentation issues
As suggested above, rigor in identifying what informa-
tion to provide does not ensure that patients will be
able to understand it, and evidence suggests that how
the information is presented can affect patients’ compre-
hension. For example, aspects of text presentation that
can affect comprehension include its structure [41,42],
layout [43,44], language [45] and font [41] (see also in
this special supplement: Abhyankar et al.’s “Balancing
the Presentation of Information and Options in Patient
Decision Aids: An Updated Review"; and McCaffery et
al.’s “Addressing Health Literacy”). While research on
many factors affecting comprehension of text is ongoing,
much more is needed in the particular context of
PtDAs. Presentation of quantitative information—such
as the chances of potential benefits and risks—can be
affected by aspects including the particular concept
Feldman-Stewart et al. BMC Medical Informatics and Decision
Making 2013, 13(Suppl 2):S4
http://www.biomedcentral.com/1472-6947/13/S2/S4
Page 5 of 9
being presented (e.g., probabilities versus frequencies)
[46], the type of visual format used, and the complexity
of information conveyed [47] (see also in this special
supplement: Trevena et al.’s “Presenting Quantitative
Information about Decision Outcomes: A Risk Commu-
nication Primer for Decision Aid Developers”). There is
active research around the presentation of quantities in
PtDA contexts, and the evidence suggests that many
particulars about a given situation will affect which pre-
sentations are most easily and accurately understood;
for example, when comparing outcomes of two options,
the format most effective for judging which quantity is
larger (or smaller) differs from the one that is most
effective for determining the exact difference between
the two [47]. Furthermore, text and numeric presenta-
tions can interact to affect comprehension [48]. More-
over, if graphics, including both quantitative and
illustrative, do not directly reinforce the textual informa-
tion, they can distract from core information and reduce
recall accuracy [49]. Finally, although evidence presented
above suggests that more detailed DAs can generally
result in small improvements in the amount of relevant
information recalled by patients, there are times when
less information results in greater comprehension [50].
See “Population-specific effects”, below, for further
information.
In addition to affecting comprehension, presentation
format can affect decision-making processes. Presenting
text in table format helps readers make direct compari-
sons, which, in turn, helps decision making [51,52]. It
should also be noted that when options are presented
sequentially (i.e., one after the other), the order in which
they are presented can shift preferences [53]. The order
in which pieces of information are presented affects how
important patients judge the particular pieces of infor-
mation to be [33]. Thus, the order of information pro-
vided can affect many types of decision processes.
Further research is needed to clarify which aspects of
presentations affect decision processes and how to
address that impact.
While some generalities exist around how information
presentation affects its potential to be understood, there is
evidence suggesting that some of these effects could be
population specific. In addition to literacy levels being
important, age may also be an important consideration,
such as when using illustrations [54]. For instance, it is
possible that older adults may have difficulty integrating
illustrations with textual information [45]. Further
research is needed to clarify what population-related fac-
tors are important considerations for how information is
presented. Beyond improving our understanding of popu-
lation-specific factors that affect comprehension and deci-
sion processes, further research is needed to clarify
whether particular aspects of clinical situations can affect
comprehension and decision processes; for example, are
there systematic differences between curative vs palliative
decisions that interact with how information is processed,
or between reversible and non-reversible decisions?
Presentation issues can go beyond those related to pre-
senting particular pieces of information. Medium-specific
considerations can also affect how well information is
understood by patients (see also in this special supple-
ment: Hoffman et al.’s “Delivering Patient Decision Aids
on the Internet”). For example, multi-media presentation
can result in poorer comprehension than when the infor-
mation is presented in a single medium, such as present-
ing auditory and text messages that are identical
compared to the text by itself. Using different media to
complement each other’s messages, however, can improve
comprehension [55], such as presenting a drawing that
reinforces the main message of text. Evidence from a sys-
tematic research program on multi-media learning pro-
vides guiding principles on how to maximize the
effectiveness of multi-media presentations [56]. Multime-
dia can be used to implement “entertainment education,”
which has resulted in higher knowledge gains for low lit-
eracy patients than audio-booklet presentation; however, it
has no apparent differential impact on high-literacy
patients [26].
We note that, while all of the above (and more)
aspects of presentation can affect what patients under-
stand, it is not clear how they affected the RCTs that
led us to conclude that PtDAs over usual care, and
more-detailed over simpler PtDAs, result in improved
patient knowledge. The one potential exception is the
low-literacy PtDA, where its results appear to reverse
the trend seen in most other simpler versus more-
detailed comparisons. The study population was also
different, however, which complicates interpretation of
the results.
Additional issues
Issues related to information in PtDAs extend beyond
defining and presenting the information. As noted
above, recall, which demands that patients store infor-
mation in memory that can be retrieved at a later time,
has been typically used to assess effectiveness of infor-
mation presentations. We suggest that further develop-
ment is required around which outcomes should be
used to assess effectiveness of presentations and when
they should be assessed. If the goal of PtDA is to assist
decision making, does a patient’s inability to recall infor-
mation that does not affect their particular decision
mean that the PtDA has not help them arrive at a well
informed decision? We suggest that understanding the
information that is provided is a necessary prerequisite
for the PtDA to be helpful. But, recall goes beyond com-
prehension, and evidence is clear that it is affected by its
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own host of factors [57]. We, therefore, suggest that in
addition to PtDA evaluations being guided by decision-
making theory [58], there should be meta-theoretical
considerations (i.e., theoretical thinking beyond the deci-
sion making theory) around which outcomes to assess
and when (see also in this special supplement: Stacey et
al.’s “Coaching and Guidance with Patient Decision
Aids: A Review of Theoretical and Empirical Evidence”).
Observations and conclusions presented here are lim-
ited in a number of ways. We relied on the Cochrane
Collaboration review [18] for assessments of the quality
of the studies they included in their review. In addition,
we restricted all studies to RCTs to rely on the highest
level of evidence but do recognize that there are numer-
ous non-randomized studies that can provide some
insights into relevant issues. Further, all the studies we
relied on were conducted in English, in Western coun-
tries. Further research is needed to clarify language and
cultural issues within those countries, and what can be
generalized beyond them. Finally, issues relevant to
information presentation that we have identified in this
paper come from very broad educational and psycholo-
gical literatures, where further guidance can be found.
Conclusions
Information about options is an important dimension of
PtDAs and its provision in PtDAs typically results in
improved knowledge in patients over usual care. More
detailed information can improve that knowledge
slightly more than simple information. How the infor-
mation is presented, however, can have a large impact
on the knowledge patients acquire, by affecting patient
ability to understand and integrate the information.
Defining the content to include in a particular PtDA
requires consultation with relevant healthcare providers
and the targeted patient population, using both qualita-
tive and quantitative approaches. The combination of the
two types of studies will ensure that developers have
both breadth and depth of understanding of the informa-
tion required and it will reveal where variation exists
within the population that needs to be addressed. Defin-
ing information that patients want requires attention to
detail in order to limit unwarranted assumptions. When
wide variation exists in the needs of patients within the
population, the PtDA process will require tailoring infor-
mation presented to the needs of the individual patient.
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